Leuthold Group, LLC Novo Nordisk A S Transaction History

Leuthold Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $458,474 - $529,588	-7,176 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $12,674 - $13,973	-199 Reduced 2.7%	7,176 $498,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $16,918 - $19,634	-289 Reduced 3.77%	7,375 $483,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $35,215 - $46,123	-712 Reduced 8.5%	7,664 $461,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $417,627 - $487,985	8,376 New	8,376 $485,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.